AMA backs update to CDC opioid prescribing guidelines
The AMA is urging the CDC to remove arbitrary thresholds, restore balance and support comprehensive, compassionate care as it revises the guidelines.
July 16, 2021: State Advocacy Update
Rhode Island is first state in nation to support pilot harm reduction center and more in the latest State Advocacy Update.
Require access to Rx for opioid-use disorder in prisons, jails
Delegates seek to ensure that evidence-based treatment for substance-use disorders, along with social support, is available in correctional facilities and upon release.
Biden administration boosts access to overdose prevention, treatment
The drug-overdose epidemic continues during the COVID-19 pandemic, but steps are being taken that will save lives and enhance access to treatment.
Why denying addiction treatment in jails, prisons is inhumane
Evidence shows medications to treat substance-use disorder treatment in jails and prisons are lifesaving, yet they’re too often denied. Learn more with the AMA.
AMA statement on HHS decision to remove addiction treatment barriers
AMA is pleased that HHS will support physicians to prescribe buprenorphine, will remove daunting regulatory barriers for patients with opioid use disorder.
Feb. 5, 2021: National Advocacy Update
Expanding patients’ access to buprenorphine and more in the latest National Advocacy Update.
Membership Moves Medicine™
- Free access to JAMA Network™ and CME
- Save hundreds on insurance
- Fight for physicians and patient rights